Hydrophobic protein in colorectal cancer in relation to tumor stages and grades

World Journal of Gastroenterology

Volumn 16, Issue 22, 2010, Pages 2754-2763

  Yeoh, Lay Chin ^a   Loh, Chee Keat ^a   Gooi, Boon Hui ^a   Singh, Manjit ^a   Gam, Lay Harn ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

2D polyacrylamide gel electrophoresis; Biomarker; Colorectal cancer; Liquid chromatography tandem mass spectrometry; Proteomic approach

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; CALRETICULIN; CHAPERONIN; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; HEAT SHOCK PROTEIN 70; LIPOCORTIN 4; LIPOCORTIN 5; PROHIBITIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; STOMATIN; TUMOR MARKER; UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 77954283113     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i22.2754     Document Type: Article

References (34)

1. World Health Organization. Cancer: Fact sheet. 2009 [cited 31th August 2009]; Available from: URL: http://www.who.int/mediacentre/factsheets/fs297/en/index.html
2. Lim GCC, Yahaya H, Lim TO. The first report of the national cancer registry, cancer incidence in malaysia. Kuala Lumpur: Ministry of Health, 2003: 57-58
3. Alessandro R, Belluco C, Kohn EC. Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery. Clin Colorectal Cancer 2005; 4: 396-402
4. Wallin E, von Heijne G. Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci 1998; 7: 1029-1038
5. Tan S, Tan HT, Chung MC. Membrane proteins and membrane proteomics. Proteomics 2008; 8: 3924-3932
6. Canelle L, Bousquet J, Pionneau C, Hardouin J, Choquet-Kastylevsky G, Joubert-Caron R, Caron M. A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins. Electrophoresis 2006; 27: 1609-1616
7. Rabilloud T. Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis 1998; 19: 758-760
8. Rabilloud T. Solubilization of proteins in 2-D electrophoresis. An outline. Methods Mol Biol 1999; 112: 9-19
9. Alvarez-Chaver P, Rodríguez-Piñeiro AM, Rodríguez-Berrocal FJ, Martínez-Zorzano VS, Páez de la Cadena M. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer. Int J Biochem Cell Biol 2007; 39: 529-540
10. Molloy MP. Two-dimensional electrophoresis of membrane proteins using immobilized pH gradients. Anal Biochem 2000; 280: 1-10
11. Dreger M. Subcellular proteomics. Mass Spectrom Rev 2003; 22: 27-56
12. Görg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004; 4: 3665-3685
13. Gam LH, Leow CH, Man CN, Gooi BH, Singh M. Analysis of differentially expressed proteins in cancerous and normal colonic tissues. World J Gastroenterol 2006; 12: 4973-4980
14. Laurière M. A semidry electroblotting system efficiently transfers both high- and low-molecular-weight proteins separated by SDS-PAGE. Anal Biochem 1993; 212: 206-211
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
16. Lund R, Leth-Larsen R, Jensen ON, Ditzel HJ. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. J Proteome Res 2009; 8: 3078-3090
17. Görg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000; 21: 1037-1053
18. Dowling P, Meleady P, Dowd A, Henry M, Glynn S, Clynes M. Proteomic analysis of isolated membrane fractions from superinvasive cancer cells. Biochim Biophys Acta 2007; 1774: 93-101
19. Deans GT, Parks TG, Rowlands BJ, Spence RA. Prognostic factors in colorectal cancer. Br J Surg 1992; 79: 608-613
20. Kwong KY, Bloom GC, Yang I, Boulware D, Coppola D, Haseman J, Chen E, McGrath A, Makusky AJ, Taylor J, Steiner S, Zhou J, Yeatman TJ, Quackenbush J. Synchronous global assessment of gene and protein expression in colorectal cancer progression. Genomics 2005; 86: 142-158
21. McCashland TM, Brand R, Lyden E, de Garmo P. Gender differences in colorectal polyps and tumors. Am J Gastroenterol 2001; 96: 882-886
22. Zhang L, Ding F, Cao W, Liu Z, Liu W, Yu Z, Wu Y, Li W, Li Y, Liu Z. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res 2006; 12: 1639-1646
23. Cao W, Zhang B, Liu Y, Li H, Zhang S, Fu L, Niu Y, Ning L, Cao X, Liu Z, Sun B. High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival. Am J Clin Pathol 2007; 128: 430-436
24. Wang Y, Morrow JS. Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem 2000; 275: 8062-8071
25. Blonder J, Goshe MB, Moore RJ, Pasa-Tolic L, Masselon CD, Lipton MS, Smith RD. Enrichment of integral membrane proteins for proteomic analysis using liquid chromatographytandem mass spectrometry. J Proteome Res 2002; 1: 351-360
26. Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC, Cho S. Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun 2005; 337: 1283-1287
27. Gökmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP. Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res 2001; 61: 1375-1381
28. Rand JH. The annexinopathies: a new category of diseases. Biochim Biophys Acta 2000; 1498: 169-173
29. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI. Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 2008; 98: 426-433
30. Zimmermann U, Balabanov S, Giebel J, Teller S, Junker H, Schmoll D, Protzel C, Scharf C, Kleist B, Walther R. Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett 2004; 209: 111-118
31. Madoz-Gúrpide J, López-Serra P, Martínez-Torrecuadrada JL, Sánchez L, Lombardía L, Casal JI. Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis. Mol Cell Proteomics 2006; 5: 1471-1483
32. Wozny W, Schroer K, Schwall GP, Poznanović S, Stegmann W, Dietz K, Rogatsch H, Schaefer G, Huebl H, Klocker H, Schrattenholz A, Cahill MA. Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: cancer association of annexin A3. Proteomics 2007; 7: 313-322
33. Sullivan KF. Structure and utilization of tubulin isotypes. Annu Rev Cell Biol 1988; 4: 687-716
34. Giarnieri E, De Francesco GP, Carico E, Midiri G, Amanti C, Giacomelli L, Tucci G, Gidaro S, Stroppa I, Gidaro G, Giovagnoli MR. Alpha- and beta-tubulin expression in rectal cancer development. Anticancer Res 2005; 25: 3237-3241